The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

New England Journal of Medicine

Volumn 334, Issue 21, 1996, Pages 1356-1361

  Recht, Abram ^a,b,c   Come, Steven E ^b   Henderson, I Craig ^c,d   Gelman, Rebecca S ^a,f   Silver, Barbara ^a   Hayes, Daniel F ^c,d   Shulman, Lawrence N ^e   Harris, Jay R ^a,b,c  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PREDNISONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ACTUARIAL ANALYSIS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECURRENCE; SURVIVAL ANALYSIS; TAMOXIFEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029878679     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605233342102     Document Type: Article

References (26)

1. Recht A, Come SE. Integration of conservative surgery, radiotherapy, and chemotherapy for patients with early-stage breast cancer. Semin Radiat Oncol 1992;2:107-15.
2. Fowble B. Interaction of chemotherapy and radiation in the treatment of nonmetastatic breast cancer. In: Meyer JL, Vaeth JM, eds. Radiotherapy/ chemotherapy interactions in cancer therapy: potential benefits and hazards in the clinic. Vol. 26 of Frontiers of radiation therapy and oncology. Basel, Switzerland: Karger, 1992:95-114.
3. Recht A, Harris JR, Come SE. Sequencing of irradiation and chemotherapy for early-stage breast cancer. Oncology (Huntingt) 1994;8(3):19-28.
4. Fisher B, Brown AM, Dimitrov NV, et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol 1990;8:1483-96.
5. Wallgren A, Bernier J, Gelber RD, Roncadin M, Joseph D, Castiglione-Gertsch M. Timing of radiotherapy (RT) and chemotherapy (CT) following breast conserving surgery (BCS) for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys 1995;32:Suppl 1:148. abstract.
6. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: J.B. Lippincott, 1993.
7. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-51.
8. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens: a clinically oriented approach. Am J Clin Pathol 1992;98:125-37.
9. Harris JR, Recht A. Conservative surgery and radiotherapy. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. 2nd ed. Philadelphia: J.B. Lippincott, 1991:388-419.
10. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990; 8:548-55.
11. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
12. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979;5:257-61.
13. Buzdar AU, Smith TL, Powell KC, Blumenschein GR, Gehan EA. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat 1982;2:163-9.
14. Dalton WS, Brooks RJ, Jones SE, et al. Breast cancer adjuvant therapy trials at the Arizona Cancer Center using adriamycin and cyclophosphamide. In: Salmon SE, ed. Adjuvant therapy of cancer V. Orlando, Fla.: Grune & Stratton, 1987:263-9.
15. The Ludwig Breast Cancer Study Group. Combination adjuvant chemotherapy for node-positive breast cancer: inadequacy of a single perioperative cycle. N Engl J Med 1988;319:677-83.
16. Sertoli MR, Bruzzi P, Pronzato P, et al. Randomized cooperative study of perioperative chemotherapy in breast cancer. J Clin Oncol 1995;13:2712-21.
17. Wood WC, Budman DR, Korzun AH, et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 1994;330:1253-9. [Erratum, N Engl J Med 1994;331:139.]
18. Recht A, Come SE. Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 1991;9: 1662-7.
19. Recht A, Coleman CN, Harris JR, Come SE, Gelman RS. Timing of radiotherapy in the treatment of early-stage breast cancer. J Clin Oncol 1993;11: 192-3.
20. Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radial Oncol Biol Phys 1993;26:23-35.
21. Buzdar AU, Kau SW, Smith TL, et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer 1993;71:3680-4.
22. Antoniades J, Chen C, Gabuzda T, et al. Stage II carcinoma of the breast treated in sequence by surgery, chemotherapy, and irradiation. Proc Am Soc Clin Oncol 1993;12:83. abstract.
23. Heimann R, Powers C, Fleming G, et al. Does the sequencing of radiotherapy and chemotherapy affect the outcome in early-stage breast cancer: a continuing question. Int J Radial Oncol Biol Phys 1994;30:Suppl 1:243-4. abstract.
24. Leonard CE, Wood ME, Zhen B, et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol 1995;13:2906-15.
25. Hartsell WF, Recine DC, Griem KL, Murthy AK. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 1995;76:2497-503.
26. McCormick B, Norton L, Yao TJ, Yahalom J, Petrek JA. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. Cancer J Sci Am 1996;2:39-45.